Clariant Ag · SIX:CLN
Clariant — Q4 2024 Earnings Presentation
38 slides from Clariant's earnings presentation, Feb 28, 2025
Slide 1: Fourth Quarter / Full Year Results 2024
Fourth Quarter / Full Year Results 2024 Analyst presentation Investor Relations 28.02.2025
Slide 2: Disclaimer
2 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Disclaimer This presentation contains certain statements that are the Company’s ability to continue to receive adequate neither reported financial results nor other historical products from its vendors on acceptable terms, or a
Slide 3: Group performance
CLARIANT™ Z Group performanc j
Slide 4: Highlights Q4 / FY 2024 Key messages
4 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Highlights Q4 / FY 2024 Key messages Key Figures in CHF – Delivering on FY 2024 guidance ✓ Low single-digit percentage decline ➔ - 3 % LC 1 091 m 179 m / 16.4 % ✓ EBITDA margin around 16 % ➔ 15.8 %, 16.0 % b.e.i.1 ▪ Solid cash
Slide 5: Q4 sales: Catalysts and Adsorbents & Additives driving organic growth
5 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Q4 sales: Catalysts and Adsorbents & Additives driving 3 % organic growth (LC1) -2% + 10 % LC +5% + 10 % in CHF 1 110 1 091 1 062 22 11 - 30 16 10 991 +2% +1% +2% +1% -3% Care Chemicals Care Chemicals flat, Positive Net impact
Slide 6: Q4 EBITDA: Improvement in Adsorbents & Additives and Catalysts
6 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Q4 EBITDA: Improvement in Adsorbents & Additives and Catalysts offsetting lower Care Chemicals + 69 % CHF 43 m restructuring + 640 bps CHF 16 m sunliquid (CHF 35 m related to 179 provision reversal sunliquid decision) -3 18 158
Slide 7: Business performance
Business performance
Slide 8: Fourth Quarter 2024 Care Chemicals Highlights
8 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Fourth Quarter 2024 Highlights Care Chemicals in CHF m Q4 2024 Q4 2023 % CHF % LC1 – Volume organically flat due to lower seasonal business Sales 560 549 2 4 (aviation and refinery), offset by low-single-digit percent EBITDA 90
Slide 9: Fourth Quarter 2024 Catalysts Highlights
9 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Fourth Quarter 2024 Highlights Catalysts in CHF m Q4 2024 Q4 2023 % CHF % LC1 – Refill cycle normalized in fourth quarter; no underlying Sales 271 258 5 7 improvement expected as economic environment remains EBITDA 68 - 10 n/a
Slide 10: Fourth Quarter 2024 Adsorbents & Additives Highlights
10 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Fourth Quarter 2024 Highlights Adsorbents & Additives in CHF m Q4 2024 Q4 2023 % CHF % LC1 – Volume increased due to growth in Additives with Polymer Sales 260 255 2 4 Solutions (> 25 %) and Coatings & Adhesives (~ 5 %); EBITD
Slide 11: 96% of CHF 175 m cost savings achieved by FY 2024
11 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 96 % of CHF 175 m cost savings Investor Day 2024 savings program achieved by FY 2024 set to deliver CHF 80 m by 2027 175 Run-rate savings of CHF 80 m through BU and Corporate actions by 2027 with significant contribution alrea
Slide 12: Outlook
Outlook ~ Greater chemistry
Slide 13: Outlook: 2025 modest top-line growth and further margin improvement
13 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Outlook: 2025 modest top-line growth and further margin improvement toward unchanged medium-term target 2025 External Factors Internal Factors – Moderation in general inflation; – Growth in Care Chemicals Top line continued hi
Slide 14: Appendix
CLARIANT™
Slide 15: Regular distribution of CHF 0.42 per share proposed
15 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Regular distribution of CHF 0.42 per share proposed based on operational 2024 performance Distribution in CHF per share / year of payout 3.001 – The Board of Directors (BoD) recommends a regular distribution of CHF 0.42 per sh
Slide 16: Modeling Guidance FY 2025 versus FY 2024
16 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Modeling Guidance FY 2025 versus FY 2024 • CHF 20 – 25 m sales impact Acquisition • CHF 8 – 10 m EBITDA impact Lucas Meyer Cosmetics • Scope effect in Q1 2025 for Care Chemicals due to closing April 2024 • Growth in Care Chemi
Slide 17: Fourth Quarter 2024 – Overview
17 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Fourth Quarter 2024 – Overview Group Care Chemicals in CHF m Q4 2024 Q4 2023 % CHF % LC1 in CHF m Q4 2024 Q4 2023 % CHF % LC1 Sales 1 091 1 062 3 5 Sales 560 549 2 4 EBITDA 179 106 69 EBITDA 90 110 - 18 EBITDA margin 16.4 % 10
Slide 18: Full Year 2024 – Overview
18 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Full Year 2024 – Overview Group Care Chemicals in CHF m FY 2024 FY 2023 % CHF % LC1 in CHF m FY 2024 FY 2023 % CHF % LC1 Sales 4 152 4 377 -5 -3 Sales 2 242 2 320 -3 -1 EBITDA 657 607 8 EBITDA 403 462 - 13 EBITDA margin 15.8 %
Slide 19: sunliquid impact
19 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 sunliquid impact 2024 in CHF m FY 24 guidance Q4 2024 FY 2024 Sales 0.4 2 Operational impact1 negative ~ 10 -2 - 10 Flat to negative 5 Total exceptional items1 +16 + 19 (prev.: up to negative 15) restructuring + 13 + 16 provis
Slide 20: Full Year 2024 – Consolidated Income Statement
20 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Full Year 2024 – Highlights Consolidated Income Statement CHF m 2024 2023 – Gross margin increased to 30.3 % due to lower energy CHF m % CHF m % Sales 4 152 100.0 4 377 100.0 and raw material costs vs. slight volume and price
Slide 21: Full Year 2024 – Cash Flow Statement
21 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Full Year 2024 – Highlights Cash Flow Statement CHF m 2024 2023 – Net cash generated from operating activities around prior Net income 280 179 Adjustment for: Depreciation and amortization 247 236 year’s level as higher earnin
Slide 22: Full Year 2024 – Balance Sheet
22 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Full Year 2024 – Balance Sheet 31.12.2024 31.12.2023 31.12.2024 31.12.2023 ASSETS CHF m % CHF m % EQUITY AND LIABILITIES CHF m % CHF m % Non-current assets Equity Property, plant, and equipment 1 524 1 439 Share capital 584 72
Slide 23: Geographic split Q4 sales
23 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Geographic split Regional headline Q4 sales CHF 1 091 m – EMEA sales flat with positive pricing offset by slightly in CHF m, % in local currency1 lower volumes. Care Chemicals with slightly lower volume (seasonal business) com
Slide 24: Geographic split FY sales
24 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Geographic split Regional headline FY sales CHF 4 152 m – EMEA sales decreased 4 %, mainly driven by lower in CHF m, % in local currency1 pricing. Growth in Catalysts, driven by European engineering partners who supplied their
Slide 25: EBITDA / EBIT Bridge Full Year 2024
25 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 EBITDA / EBIT Bridge Full Year 2024 Group continuing operations (CHF m) Care Chemicals (CHF m) EBITDA Exceptional Exceptional EBITDA Exceptional Exceptional bei items EBITDA D&I1 EBITA Amortization EBIT items EBIT bei bei item
Slide 26: ROIC vs. cost of capital
26 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 ROIC vs. cost of capital Future improvement drivers ROIC1 in % 3 10.6 % 9.9 % 4 Cost of 9.5 % 7.7 % 2 9.2 % capital: − Organic growth 7.4 % ~ 8.5 % − Increasing operating margin 6.6 % − Reducing nonoperating cost (reported) 1.
Slide 27: Cost dynamics – Pricing and volumes
27 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Cost dynamics – year-on-year and Q4 2024: Pricing and volumes sequentially mixed slightly up − Raw materials in Q4 decreased year-on-year (sequential flat) − Recessionary economic environment maintained in Q4 2023 − Energy in
Slide 28: Exposure to attractive consumer markets, accelerating demand for sustainable products
28 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Exposure to attractive consumer markets of close to 50 %... …with accelerating demand for sustainable products Sales by End Market 2021 (Total Group) Sales by End Market FY 2024 Chemical Chemical Process Process Consumer (Cata
Slide 29: ESG – Clariant's Sustainability Transformation Commitment
29 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 ESG – Clariant’s Sustainability Transformation Commitment Sustainability priorities Investment in operations and portfolio Fighting Climate Change Increasing Circularity Sustainable operations Reducing our own carbon Products
Slide 30: Significant improvement of non-financial KPIs
30 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Significant improvement of non-financial KPIs – Fully on track to deliver updated 2030 greenhouse gas (GHG) targets Reducing corporate GHG emissions New operating model driving customer satisfaction and 46.9 % reduction employ
Slide 31: Clariant's Leading Sustainability Ratings and Rankings
31 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Clariant’s Leading Sustainability Ratings and Rankings Status as of February 2025 Index / Ranking / Clariant Score / Percentile First Year of Status Rating Rank or Range Inclusion 32 % 12 % 14 % 17 % 7% 8% 10 % AA / Range: AAA
Slide 32: Debt Maturity Profile as of 31 December 2024
32 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Debt Maturity Profile as of 31 December 2024 Cash and short-term deposits CHF bond Certificates of indebtedness Liquidity Financial debt maturities in CHF m in CHF m 441 395 200 331 214 223 166 146 331 175 150 200 1501 66 73 1
Slide 33: Full Year 2024 Top 20 Chemicals in Total Raw Material Cost
33 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Full Year 2024 Top 20 Chemicals in Percentage of Total Raw Material Cost TOP 5 CHEMICALS TOP 6 - 20 CHEMICALS 1 Ethylene 6 Methyloxirane 2 Propane-1,2-diol 7 Aluminium Oxide 3 Ethylene Oxide 8 Phosphinic Acid, sodium salt, hyd
Slide 34: Full Year 2024 – Sales and Cost Structure (indicative)
34 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Full Year 2024 – Sales and Cost Structure (indicative) Global Sales Distribution1 Global Cost Distribution 2 in % in % Other 8% JPY Other JPY 2% 4% 15 % BRL EUR 4% 36 % BRL 6% EUR 28 % INR INR 5% 6% CNY 7% CNY 8% USD USD 34 %
Slide 35: Calendar of Upcoming Corporate Events
35 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 Calendar of Upcoming Corporate Events 5 March 2025 29 April 2025 30 October 2025 Integrated Report First Quarter Third Quarter / 2025 Reporting Nine Month 2025 Reporting 28 February 2025 1 April 2025 31 July 2025 Fourth Quarte
Slide 36: The Executive Leadership Team
36 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 The Executive Leadership Team Conrad Keijzer Chief Executive Officer Executive Leadership Team Executive Steering Committee Christian Vang Jens Cuntze Angela Cackovich Bill Collins Tatiana Berardinelli Judith Bischof Richard H
Slide 37: IR Contacts
37 Fourth Quarter / Full Year Results 2024 Investor Relations, 28.02.2025 IR Contacts ANDREAS SCHWARZWÄLDER Head of Investor Relations Phone: +41 61 469 63 73 Email: investor-relations@clariant.com THIJS BOUWENS Investor Relations Officer Phone: +41 61 469 63 73 Email: investor-relations@clariant.co
Slide 38: Thank you
Thank you